CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
299.000 |
Evidence |
|
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
299.000 |
Evidence |
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
299.000 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
299.000 |
Evidence |
O
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
299.000 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
STAT3 |
|
299.000 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
299.000 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
299.000 |
Evidence |
|
PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
299.000 |
Evidence |
|
HCK |
IPI00029769 |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
294.000 |
Evidence |
|
PSMD10 |
PSMD10: 26S proteasome non-ATPase regulatory subunit 10 |
PSMC3 |
PSMC3, TBP1: 26S protease regulatory subunit 6A |
293.000 |
Evidence |
O
|
GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
293.000 |
Evidence |
O
|
PSMD11 |
PSMD11: 26S proteasome non-ATPase regulatory subunit 11 |
PSMD13 |
PSMD13: 26S proteasome non-ATPase regulatory subunit 13 |
280.000 |
Evidence |
O
|
PSMD3 |
PSMD3: 26S proteasome non-ATPase regulatory subunit 3 |
PSMD11 |
PSMD11: 26S proteasome non-ATPase regulatory subunit 11 |
280.000 |
Evidence |
O
|
PSMA2 |
PSMA2, PSC3: Proteasome subunit alpha type-2 |
PSMB6 |
PSMB6, LMPY: Proteasome subunit beta type-6 precursor |
280.000 |
Evidence |
O
|
LSM8 |
LSM8: U6 snRNA-associated Sm-like protein LSm8 |
LSM4 |
LSM4: U6 snRNA-associated Sm-like protein LSm4 |
279.000 |
Evidence |
O
|
RFX1 |
RFX1: MHC class II regulatory factor RFX1 |
RFX2 |
RFX2: DNA-binding protein RFX2 |
276.000 |
Evidence |
O
|
CHMP6 |
CHMP6, VPS20: Charged multivesicular body protein 6 |
CHMP4B |
CHMP4B, C20orf178, SHAX1: Charged multivesicular body protein 4b |
276.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
CRKL |
CRKL: Crk-like protein |
275.000 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
275.000 |
Evidence |
|
PSMC3 |
PSMC3, TBP1: 26S protease regulatory subunit 6A |
TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
272.000 |
Evidence |
O
|
CNAP1 |
NCAPD2, CAPD2, CNAP1, KIAA0159: Condensin complex subunit 1 |
SMC4L1 |
SMC4, CAPC, SMC4L1: Structural maintenance of chromosomes protein 4 |
269.000 |
Evidence |
|
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
JAK1 |
|
268.000 |
Evidence |
|
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
CRKL |
CRKL: Crk-like protein |
268.000 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
JAK1 |
|
268.000 |
Evidence |
|